Development of a cell-based fluorescence resonance energy transfer reporter for Bacillus anthracis lethal factor protease

Analytical Biochemistry

Volumn 369, Issue 1, 2007, Pages 60-70

  Kimura, Richard H ^a   Steenblock, Erin R ^a   Camarero, Julio A ^a  

^a LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

Author keywords

Anthrax; Cell biosensing; FRET based reporter; In vivo screening; Metalloprotease

Indexed keywords

BACTERIOLOGY; CELL CULTURE; CELLS; DISEASES; ENERGY TRANSFER; ESCHERICHIA COLI; FORSTER RESONANCE ENERGY TRANSFER; PROTEINS;

ANTHRAX; BIOSENSING; FRET-BASED REPORTER; IN-VIVO; METALLO-PROTEASE;

CELL ENGINEERING;

PROTEINASE;

ARTICLE; BACILLUS ANTHRACIS; ENZYME ACTIVITY; ESCHERICHIA COLI; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE SEQUENCE; GENETIC CODE; GENETIC SCREENING; LETHAL GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BACILLUS ANTHRACIS; ESCHERICHIA COLI;

EID: 34548161821     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2007.05.014     Document Type: Article

References (49)

1. Leppla S.H. Anthrax toxin edema factor: A bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc. Natl. Acad. Sci. USA 79 (1982) 3162-3166
2. Klimpel K.R., Arora N., and Leppla S.H. Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity. Mol. Microbiol. 13 (1994) 1093-1100
3. Montecucco C., Tonello F., and Zanotti G. Stop the killer: How to inhibit the anthrax lethal factor metalloprotease. Trends Biochem. Sci. 29 (2004) 282-285
4. Bradley K.A., Mogridge J., Mourez M., Collier R.J., and Young J.A. Identification of the cellular receptor for anthrax toxin. Nature 414 (2001) 225-229
5. Scobie H.M., Rainey G.J., Bradley K.A., and Young J.A. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc. Natl. Acad. Sci. USA 100 (2003) 5170-5174
6. Santelli E., Bankston L.A., Leppla S.H., and Liddington R.C. Crystal structure of a complex between anthrax toxin and its host cell receptor. Nature 430 (2004) 905-908
7. Gordon V.M., Klimpel K.R., Arora N., Henderson M.A., and Leppla S.H. Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases. Infect. Immun. 63 (1995) 82-87
8. Milne J.C., Furlong D., Hanna P.C., Wall J.S., and Collier R.J. Anthrax protective antigen forms oligomers during intoxication of mammalian cells. J. Biol. Chem. 269 (1994) 20607-20612
9. Park J.M., Greten F.R., Li Z.W., and Karin M. Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science 297 (2002) 2048-2051
10. Kirby J.E. Anthrax lethal toxin induces human endothelial cell apoptosis. Infect. Immun. 72 (2004) 430-439
11. Agrawal A., Lingappa J., Leppla S.H., Agrawal S., Jabbar A., Quinn C., and Pulendran B. Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin. Nature 424 (2003) 329-334
12. Forino M., Johnson S., Wong T.Y., Rozanov D.V., Savinov A.Y., Li W., Fattorusso R., Becattini B., Orry A.J., Jung D., Abagyan R.A., Smith J.W., Alibek K., Liddington R.C., Strongin A.Y., and Pellecchia M. Efficient synthetic inhibitors of anthrax lethal factor. Proc. Natl. Acad. Sci. USA 102 (2005) 9499-9504
13. Xiong Y., Wiltsie J., Woods A., Guo J., Pivnichny J.V., Tang W., Bansal A., Cummings R.T., Cunningham B.R., Friedlander A.M., Douglas C.M., Salowe S.P., Zaller D.M., Scolnick E.M., Schmatz D.M., Bartizal K., Hermes J.D., MacCoss M., and Chapman K.T. The discovery of a potent and selective lethal factor inhibitor for adjunct therapy of anthrax infection. Bioorg. Med. Chem. Lett. 16 (2006) 964-968
14. Mullen L.M., Nair S.P., Ward J.M., Rycroft A.N., and Henderson B. Phage display in the study of infectious diseases. Trends Microbiol. 14 (2006) 141-147
15. Hammond S.E., and Hanna P.C. Lethal factor active-site mutations affect catalytic activity in vitro. Infect. Immun. 66 (1998) 2374-2378
16. Duesbery N.S., Webb C.P., Leppla S.H., Gordon V.M., Klimpel K.R., Copeland T.D., Ahn N.G., Oskarsson M.K., Fukasawa K., Paull K.D., and Vande Woude G.F. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science 280 (1998) 734-737
17. Vitale G., Bernardi L., Napolitani G., Mock M., and Montecucco C. Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor. Biochem. J. 352 (2000) 739-745
18. Mock M., and Roques B.P. Progress in rapid screening of Bacillus anthracis lethal factor activity. Proc. Natl. Acad. Sci. USA 99 (2002) 6527-6529
19. Tonello F., Seveso M., Marin O., Mock M., and Montecucco C. Screening inhibitors of anthrax lethal factor. Nature 418 (2002) 386
20. Kwon Y., Welsh K., Mitchell A.R., and Camarero J.A. Preparation of peptide p -nitroanilides using an aryl hydrazine resin. Org. Lett. 6 (2004) 3801-3804
21. Schepetkin I.A., Khlebnikov A.I., Kirpotina L.N., and Quinn M.T. Novel small-molecule inhibitors of anthrax lethal factor identified by high-throughput screening. J. Med. Chem. 49 (2006) 5232-5244
22. Shaner N.C., Steinbach P.A., and Tsien R.Y. A guide to choosing fluorescent proteins. Nat. Methods 2 (2005) 905-909
23. Giepmans B.N., Adams S.R., Ellisman M.H., and Tsien R.Y. The fluorescent toolbox for assessing protein location and function. Science 312 (2006) 217-224
24. Nguyen A.W., and Daugherty P.S. Evolutionary optimization of fluorescent proteins for intracellular FRET. Nat. Biotechnol. 23 (2005) 355-360
25. Boulware K.T., and Daugherty P.S. Protease specificity determination by using cellular libraries of peptide substrates (CLiPS). Proc. Natl. Acad. Sci. USA 103 (2006) 7583-7588
26. Kaganman I. FRETting for a more detailed interactome. Nat. Methods 4 (2007) 112-113
27. Camarero J.A., and Muir T.W. Biosynthesis of a head-to-tail cyclized protein with improved biological activity. J. Am. Chem. Soc. 121 (1999) 5597-5598
28. Scott C.P., Abel-Santos E., Wall M., Wahnon D., and Benkovic S.J. Production of cyclic peptides and proteins in vivo. Proc. Natl. Acad. Sci. USA 96 (1999) 13638-13643
29. Trauger J.W., Kohli R.M., Mootz H.D., Marahiel M.A., and Walsh C.T. Peptide cyclization catalysed by the thioesterase domain of tyrocidine synthetase. Nature 407 (2000) 215-218
30. Kohli R.M., Walsh C.T., and Burkart M.D. Biomimetic synthesis and optimization of cyclic peptide antibiotics. Nature 418 (2002) 658-661
31. Kimura R., and Camarero J.A. Expressed protein ligation: A new tool for the biosynthesis of cyclic polypeptides. Protein Peptide Lett. 12 (2005) 789-794
32. Kimura R.H., Tran A.T., and Camarero J.A. Biosynthesis of the cyclotide kalata B1 by using protein splicing. Angew. Chem. Intl. Ed. 45 (2006) 973-976
33. Wang W., Mulakala C., Ward S.C., Jung G., Luong H., Pham D., Waring A.J., Kaznessis Y., Lu W., Bradley K.A., and Lehrer R.I. Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin. J. Biol. Chem. 281 (2006) 32755-32764
34. Kim C., Gajendran N., Mittrucker H.W., Weiwad M., Song Y.H., Hurwitz R., Wilmanns M., Fischer G., and Kaufmann S.H. Human (-defensins neutralize anthrax lethal toxin and protect against its fatal consequences. Proc. Natl. Acad. Sci. USA 102 (2005) 4830-4835
35. Lee L.V., Bower K.E., Liang F.S., Shi J., Wu D., Sucheck S.J., Vogt P.K., and Wong C.H. Inhibition of the proteolytic activity of anthrax lethal factor by aminoglycosides. J. Am. Chem. Soc. 126 (2004) 4774-4775
36. Turk B.E., Wong T.Y., Schwarzenbacher R., Jarrell E.T., Leppla S.H., Collier R.J., Liddington R.C., and Cantley L.C. The structural basis for substrate and inhibitor selectivity of the anthrax lethal factor. Nat. Struct. Mol. Biol. 11 (2004) 60-66
37. Fields G.B., and Noble R.L. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Intl. J. Peptide Protein Res. 35 (1990) 161-214
38. Sarin V.K., Kent S.B.H., Tam J.P., and Merrifield R.B. Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction. Anal. Biochem. 117 (1981) 147-157
39. You X., Nguyen A.W., Jabaiah A., Sheff M.A., Thorn K.S., and Daugherty P.S. Intracellular protein interaction mapping with FRET hybrids. Proc. Natl. Acad. Sci. USA 103 (2006) 18458-18463
40. Pannifer A.D., Wong T.Y., Schwarzenbacher R., Renatus M., Petosa C., Bienkowska J., Lacy D.B., Collier R.J., Park S., Leppla S.H., Hanna P., and Liddington R.C. Crystal structure of the anthrax lethal factor. Nature 414 (2001) 229-233
41. Evers T.H., van Dongen E.M., Faesen A.C., Meijer E.W., and Merkx M. Quantitative understanding of the energy transfer between fluorescent proteins connected via flexible peptide linkers. Biochemistry 45 (2006) 13183-13192
42. E. M. Dongen, T. H. Evers, L. M. Dekkers, E. W. Meijer, L. W. Klomp, M. Merkx, Variation of linker length in ratiometric fluorescent sensor proteins allows rational tuning of Zn(II) affinity in the picomolar to femtomolar range, J. Am. Chem. Soc. (in press).
43. Som T., and Tomizawa J. Origin of replication of Escherichia coli plasmid RSF 1030. Mol. Gen. Genet. 187 (1982) 375-383
44. Burz D.S., Dutta K., Cowburn D., and Shekhtman A. Mapping structural interactions using in-cell NMR spectroscopy (STINT-NMR). Nat. Methods 3 (2006) 91-93
45. Grossman T.H., Kawasaki E.S., Punreddy S.R., and Osburne M.S. Spontaneous cAMP-dependent derepression of gene expression in stationary phase plays a role in recombinant expression instability. Gene 209 (1998) 95-103
46. Boomershine W.P., Raj M.L., Gopalan V., and Foster M.P. Preparation of uniformly labeled NMR samples in Escherichia coli under the tight control of the araBAD promoter: Expression of an archaeal homolog of the RNase P Rpp29 protein. Protein Expr. Purif. 28 (2003) 246-251
47. Camarero J.A., Kimura R., and Tran A.T. A cell-based approach for biosynthesis/screening of cyclic peptide libraries against bacterial toxins. J. Peptide Sci. 12 Suppl.1 (2006) 89
48. Craik D.J., Simonsen S., and Daly N.L. The cyclotides: Novel macrocyclic peptides as scaffolds in drug design. Curr. Opin. Drug Discov. Dev. 5 (2002) 251-260
49. Korsinczky M.L., Schirra H.J., and Craik D.J. Sunflower trypsin inhibitor-1. Curr. Protein Peptide Sci. 5 (2004) 351-364